Global Flu (Influenza) Vaccine Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Based on the Flu (Influenza) Vaccine market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Flu (Influenza) Vaccine market covered in Chapter 5:
Pfizer
Novavax
Emergent BioSolutions
Sanofi Pasteur
CSL (Novartis)
Inovio Pharmaceuticals
Bavarian Nordic
GlaxoSmithKline
Merck & Co
Mitsubishi Tanabe Pharma
In Chapter 6, on the basis of types, the Flu (Influenza) Vaccine market from 2015 to 2025 is primarily split into:
Inactivated Influenza Vaccines (IIV)
Live Attenuated Influenza Vaccines (LAIV)
In Chapter 7, on the basis of applications, the Flu (Influenza) Vaccine market from 2015 to 2025 covers:
For Children (6 months to 3 years)
For Adults and Children over 3 years
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Flu (Influenza) Vaccine market covered in Chapter 5:
Pfizer
Novavax
Emergent BioSolutions
Sanofi Pasteur
CSL (Novartis)
Inovio Pharmaceuticals
Bavarian Nordic
GlaxoSmithKline
Merck & Co
Mitsubishi Tanabe Pharma
In Chapter 6, on the basis of types, the Flu (Influenza) Vaccine market from 2015 to 2025 is primarily split into:
Inactivated Influenza Vaccines (IIV)
Live Attenuated Influenza Vaccines (LAIV)
In Chapter 7, on the basis of applications, the Flu (Influenza) Vaccine market from 2015 to 2025 covers:
For Children (6 months to 3 years)
For Adults and Children over 3 years
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 MARKET OVERVIEW
1.1 Product Definition and Market Characteristics
1.2 Global Flu (Influenza) Vaccine Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Pfizer
5.1.1 Pfizer Company Profile
5.1.2 Pfizer Business Overview
5.1.3 Pfizer Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Pfizer Flu (Influenza) Vaccine Products Introduction
5.2 Novavax
5.2.1 Novavax Company Profile
5.2.2 Novavax Business Overview
5.2.3 Novavax Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Novavax Flu (Influenza) Vaccine Products Introduction
5.3 Emergent BioSolutions
5.3.1 Emergent BioSolutions Company Profile
5.3.2 Emergent BioSolutions Business Overview
5.3.3 Emergent BioSolutions Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Emergent BioSolutions Flu (Influenza) Vaccine Products Introduction
5.4 Sanofi Pasteur
5.4.1 Sanofi Pasteur Company Profile
5.4.2 Sanofi Pasteur Business Overview
5.4.3 Sanofi Pasteur Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Sanofi Pasteur Flu (Influenza) Vaccine Products Introduction
5.5 CSL (Novartis)
5.5.1 CSL (Novartis) Company Profile
5.5.2 CSL (Novartis) Business Overview
5.5.3 CSL (Novartis) Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 CSL (Novartis) Flu (Influenza) Vaccine Products Introduction
5.6 Inovio Pharmaceuticals
5.6.1 Inovio Pharmaceuticals Company Profile
5.6.2 Inovio Pharmaceuticals Business Overview
5.6.3 Inovio Pharmaceuticals Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Inovio Pharmaceuticals Flu (Influenza) Vaccine Products Introduction
5.7 Bavarian Nordic
5.7.1 Bavarian Nordic Company Profile
5.7.2 Bavarian Nordic Business Overview
5.7.3 Bavarian Nordic Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Bavarian Nordic Flu (Influenza) Vaccine Products Introduction
5.8 GlaxoSmithKline
5.8.1 GlaxoSmithKline Company Profile
5.8.2 GlaxoSmithKline Business Overview
5.8.3 GlaxoSmithKline Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 GlaxoSmithKline Flu (Influenza) Vaccine Products Introduction
5.9 Merck & Co
5.9.1 Merck & Co Company Profile
5.9.2 Merck & Co Business Overview
5.9.3 Merck & Co Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Merck & Co Flu (Influenza) Vaccine Products Introduction
5.10 Mitsubishi Tanabe Pharma
5.10.1 Mitsubishi Tanabe Pharma Company Profile
5.10.2 Mitsubishi Tanabe Pharma Business Overview
5.10.3 Mitsubishi Tanabe Pharma Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Mitsubishi Tanabe Pharma Flu (Influenza) Vaccine Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Flu (Influenza) Vaccine Sales and Market Share by Types (2015-2020)
6.1.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Types (2015-2020)
6.1.3 Global Flu (Influenza) Vaccine Price by Types (2015-2020)
6.2 Global Flu (Influenza) Vaccine Market Forecast by Types (2020-2025)
6.2.1 Global Flu (Influenza) Vaccine Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Flu (Influenza) Vaccine Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Flu (Influenza) Vaccine Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Flu (Influenza) Vaccine Sales, Price and Growth Rate of Inactivated Influenza Vaccines (IIV)
6.3.2 Global Flu (Influenza) Vaccine Sales, Price and Growth Rate of Live Attenuated Influenza Vaccines (LAIV)
6.4 Global Flu (Influenza) Vaccine Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Inactivated Influenza Vaccines (IIV) Market Revenue and Sales Forecast (2020-2025)
6.4.2 Live Attenuated Influenza Vaccines (LAIV) Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Flu (Influenza) Vaccine Sales and Market Share by Applications (2015-2020)
7.1.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Applications (2015-2020)
7.2 Global Flu (Influenza) Vaccine Market Forecast by Applications (2020-2025)
7.2.1 Global Flu (Influenza) Vaccine Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Flu (Influenza) Vaccine Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Flu (Influenza) Vaccine Revenue, Sales and Growth Rate of For Children (6 months to 3 years) (2015-2020)
7.3.2 Global Flu (Influenza) Vaccine Revenue, Sales and Growth Rate of For Adults and Children over 3 years (2015-2020)
7.4 Global Flu (Influenza) Vaccine Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 For Children (6 months to 3 years) Market Revenue and Sales Forecast (2020-2025)
7.4.2 For Adults and Children over 3 years Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global Flu (Influenza) Vaccine Sales by Regions (2015-2020)
8.2 Global Flu (Influenza) Vaccine Market Revenue by Regions (2015-2020)
8.3 Global Flu (Influenza) Vaccine Market Forecast by Regions (2020-2025)
9 NORTH AMERICA FLU (INFLUENZA) VACCINE MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
9.3 North America Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
9.4 North America Flu (Influenza) Vaccine Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Flu (Influenza) Vaccine Market Analysis by Country
9.6.1 U.S. Flu (Influenza) Vaccine Sales and Growth Rate
9.6.2 Canada Flu (Influenza) Vaccine Sales and Growth Rate
9.6.3 Mexico Flu (Influenza) Vaccine Sales and Growth Rate
10 EUROPE FLU (INFLUENZA) VACCINE MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
10.3 Europe Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
10.4 Europe Flu (Influenza) Vaccine Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Flu (Influenza) Vaccine Market Analysis by Country
10.6.1 Germany Flu (Influenza) Vaccine Sales and Growth Rate
10.6.2 United Kingdom Flu (Influenza) Vaccine Sales and Growth Rate
10.6.3 France Flu (Influenza) Vaccine Sales and Growth Rate
10.6.4 Italy Flu (Influenza) Vaccine Sales and Growth Rate
10.6.5 Spain Flu (Influenza) Vaccine Sales and Growth Rate
10.6.6 Russia Flu (Influenza) Vaccine Sales and Growth Rate
11 ASIA-PACIFIC FLU (INFLUENZA) VACCINE MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Flu (Influenza) Vaccine Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Flu (Influenza) Vaccine Market Analysis by Country
11.6.1 China Flu (Influenza) Vaccine Sales and Growth Rate
11.6.2 Japan Flu (Influenza) Vaccine Sales and Growth Rate
11.6.3 South Korea Flu (Influenza) Vaccine Sales and Growth Rate
11.6.4 Australia Flu (Influenza) Vaccine Sales and Growth Rate
11.6.5 India Flu (Influenza) Vaccine Sales and Growth Rate
12 SOUTH AMERICA FLU (INFLUENZA) VACCINE MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
12.3 South America Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
12.4 South America Flu (Influenza) Vaccine Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Flu (Influenza) Vaccine Market Analysis by Country
12.6.1 Brazil Flu (Influenza) Vaccine Sales and Growth Rate
12.6.2 Argentina Flu (Influenza) Vaccine Sales and Growth Rate
12.6.3 Columbia Flu (Influenza) Vaccine Sales and Growth Rate
13 MIDDLE EAST AND AFRICA FLU (INFLUENZA) VACCINE MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Flu (Influenza) Vaccine Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Flu (Influenza) Vaccine Market Analysis by Country
13.6.1 UAE Flu (Influenza) Vaccine Sales and Growth Rate
13.6.2 Egypt Flu (Influenza) Vaccine Sales and Growth Rate
13.6.3 South Africa Flu (Influenza) Vaccine Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
1.1 Product Definition and Market Characteristics
1.2 Global Flu (Influenza) Vaccine Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Pfizer
5.1.1 Pfizer Company Profile
5.1.2 Pfizer Business Overview
5.1.3 Pfizer Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Pfizer Flu (Influenza) Vaccine Products Introduction
5.2 Novavax
5.2.1 Novavax Company Profile
5.2.2 Novavax Business Overview
5.2.3 Novavax Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Novavax Flu (Influenza) Vaccine Products Introduction
5.3 Emergent BioSolutions
5.3.1 Emergent BioSolutions Company Profile
5.3.2 Emergent BioSolutions Business Overview
5.3.3 Emergent BioSolutions Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Emergent BioSolutions Flu (Influenza) Vaccine Products Introduction
5.4 Sanofi Pasteur
5.4.1 Sanofi Pasteur Company Profile
5.4.2 Sanofi Pasteur Business Overview
5.4.3 Sanofi Pasteur Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Sanofi Pasteur Flu (Influenza) Vaccine Products Introduction
5.5 CSL (Novartis)
5.5.1 CSL (Novartis) Company Profile
5.5.2 CSL (Novartis) Business Overview
5.5.3 CSL (Novartis) Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 CSL (Novartis) Flu (Influenza) Vaccine Products Introduction
5.6 Inovio Pharmaceuticals
5.6.1 Inovio Pharmaceuticals Company Profile
5.6.2 Inovio Pharmaceuticals Business Overview
5.6.3 Inovio Pharmaceuticals Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Inovio Pharmaceuticals Flu (Influenza) Vaccine Products Introduction
5.7 Bavarian Nordic
5.7.1 Bavarian Nordic Company Profile
5.7.2 Bavarian Nordic Business Overview
5.7.3 Bavarian Nordic Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Bavarian Nordic Flu (Influenza) Vaccine Products Introduction
5.8 GlaxoSmithKline
5.8.1 GlaxoSmithKline Company Profile
5.8.2 GlaxoSmithKline Business Overview
5.8.3 GlaxoSmithKline Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 GlaxoSmithKline Flu (Influenza) Vaccine Products Introduction
5.9 Merck & Co
5.9.1 Merck & Co Company Profile
5.9.2 Merck & Co Business Overview
5.9.3 Merck & Co Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Merck & Co Flu (Influenza) Vaccine Products Introduction
5.10 Mitsubishi Tanabe Pharma
5.10.1 Mitsubishi Tanabe Pharma Company Profile
5.10.2 Mitsubishi Tanabe Pharma Business Overview
5.10.3 Mitsubishi Tanabe Pharma Flu (Influenza) Vaccine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Mitsubishi Tanabe Pharma Flu (Influenza) Vaccine Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Flu (Influenza) Vaccine Sales and Market Share by Types (2015-2020)
6.1.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Types (2015-2020)
6.1.3 Global Flu (Influenza) Vaccine Price by Types (2015-2020)
6.2 Global Flu (Influenza) Vaccine Market Forecast by Types (2020-2025)
6.2.1 Global Flu (Influenza) Vaccine Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Flu (Influenza) Vaccine Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Flu (Influenza) Vaccine Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Flu (Influenza) Vaccine Sales, Price and Growth Rate of Inactivated Influenza Vaccines (IIV)
6.3.2 Global Flu (Influenza) Vaccine Sales, Price and Growth Rate of Live Attenuated Influenza Vaccines (LAIV)
6.4 Global Flu (Influenza) Vaccine Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Inactivated Influenza Vaccines (IIV) Market Revenue and Sales Forecast (2020-2025)
6.4.2 Live Attenuated Influenza Vaccines (LAIV) Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global Flu (Influenza) Vaccine Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Flu (Influenza) Vaccine Sales and Market Share by Applications (2015-2020)
7.1.2 Global Flu (Influenza) Vaccine Revenue and Market Share by Applications (2015-2020)
7.2 Global Flu (Influenza) Vaccine Market Forecast by Applications (2020-2025)
7.2.1 Global Flu (Influenza) Vaccine Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Flu (Influenza) Vaccine Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Flu (Influenza) Vaccine Revenue, Sales and Growth Rate of For Children (6 months to 3 years) (2015-2020)
7.3.2 Global Flu (Influenza) Vaccine Revenue, Sales and Growth Rate of For Adults and Children over 3 years (2015-2020)
7.4 Global Flu (Influenza) Vaccine Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 For Children (6 months to 3 years) Market Revenue and Sales Forecast (2020-2025)
7.4.2 For Adults and Children over 3 years Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global Flu (Influenza) Vaccine Sales by Regions (2015-2020)
8.2 Global Flu (Influenza) Vaccine Market Revenue by Regions (2015-2020)
8.3 Global Flu (Influenza) Vaccine Market Forecast by Regions (2020-2025)
9 NORTH AMERICA FLU (INFLUENZA) VACCINE MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
9.3 North America Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
9.4 North America Flu (Influenza) Vaccine Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Flu (Influenza) Vaccine Market Analysis by Country
9.6.1 U.S. Flu (Influenza) Vaccine Sales and Growth Rate
9.6.2 Canada Flu (Influenza) Vaccine Sales and Growth Rate
9.6.3 Mexico Flu (Influenza) Vaccine Sales and Growth Rate
10 EUROPE FLU (INFLUENZA) VACCINE MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
10.3 Europe Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
10.4 Europe Flu (Influenza) Vaccine Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Flu (Influenza) Vaccine Market Analysis by Country
10.6.1 Germany Flu (Influenza) Vaccine Sales and Growth Rate
10.6.2 United Kingdom Flu (Influenza) Vaccine Sales and Growth Rate
10.6.3 France Flu (Influenza) Vaccine Sales and Growth Rate
10.6.4 Italy Flu (Influenza) Vaccine Sales and Growth Rate
10.6.5 Spain Flu (Influenza) Vaccine Sales and Growth Rate
10.6.6 Russia Flu (Influenza) Vaccine Sales and Growth Rate
11 ASIA-PACIFIC FLU (INFLUENZA) VACCINE MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Flu (Influenza) Vaccine Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Flu (Influenza) Vaccine Market Analysis by Country
11.6.1 China Flu (Influenza) Vaccine Sales and Growth Rate
11.6.2 Japan Flu (Influenza) Vaccine Sales and Growth Rate
11.6.3 South Korea Flu (Influenza) Vaccine Sales and Growth Rate
11.6.4 Australia Flu (Influenza) Vaccine Sales and Growth Rate
11.6.5 India Flu (Influenza) Vaccine Sales and Growth Rate
12 SOUTH AMERICA FLU (INFLUENZA) VACCINE MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
12.3 South America Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
12.4 South America Flu (Influenza) Vaccine Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Flu (Influenza) Vaccine Market Analysis by Country
12.6.1 Brazil Flu (Influenza) Vaccine Sales and Growth Rate
12.6.2 Argentina Flu (Influenza) Vaccine Sales and Growth Rate
12.6.3 Columbia Flu (Influenza) Vaccine Sales and Growth Rate
13 MIDDLE EAST AND AFRICA FLU (INFLUENZA) VACCINE MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Flu (Influenza) Vaccine Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Flu (Influenza) Vaccine Market Analysis by Country
13.6.1 UAE Flu (Influenza) Vaccine Sales and Growth Rate
13.6.2 Egypt Flu (Influenza) Vaccine Sales and Growth Rate
13.6.3 South Africa Flu (Influenza) Vaccine Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Product Picture
Figure Global Flu (Influenza) Vaccine Market Size and Growth Rate 2015-2025
Table Flu (Influenza) Vaccine Key Market Segments
Figure Global Flu (Influenza) Vaccine Market Revenue ($) Segment by Type from 2015-2020
Figure Global Flu (Influenza) Vaccine Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Flu (Influenza) Vaccine
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Pfizer Company Profile
Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Production and Growth Rate
Figure Pfizer Market Revenue ($) Market Share 2015-2020
Table Novavax Company Profile
Table Novavax Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novavax Production and Growth Rate
Figure Novavax Market Revenue ($) Market Share 2015-2020
Table Emergent BioSolutions Company Profile
Table Emergent BioSolutions Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Emergent BioSolutions Production and Growth Rate
Figure Emergent BioSolutions Market Revenue ($) Market Share 2015-2020
Table Sanofi Pasteur Company Profile
Table Sanofi Pasteur Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sanofi Pasteur Production and Growth Rate
Figure Sanofi Pasteur Market Revenue ($) Market Share 2015-2020
Table CSL (Novartis) Company Profile
Table CSL (Novartis) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure CSL (Novartis) Production and Growth Rate
Figure CSL (Novartis) Market Revenue ($) Market Share 2015-2020
Table Inovio Pharmaceuticals Company Profile
Table Inovio Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Inovio Pharmaceuticals Production and Growth Rate
Figure Inovio Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Bavarian Nordic Company Profile
Table Bavarian Nordic Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bavarian Nordic Production and Growth Rate
Figure Bavarian Nordic Market Revenue ($) Market Share 2015-2020
Table GlaxoSmithKline Company Profile
Table GlaxoSmithKline Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Market Revenue ($) Market Share 2015-2020
Table Merck & Co Company Profile
Table Merck & Co Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Merck & Co Production and Growth Rate
Figure Merck & Co Market Revenue ($) Market Share 2015-2020
Table Mitsubishi Tanabe Pharma Company Profile
Table Mitsubishi Tanabe Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Mitsubishi Tanabe Pharma Production and Growth Rate
Figure Mitsubishi Tanabe Pharma Market Revenue ($) Market Share 2015-2020
Table Global Flu (Influenza) Vaccine Sales by Types (2015-2020)
Table Global Flu (Influenza) Vaccine Sales Share by Types (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue ($) by Types (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue Share by Types (2015-2020)
Table Global Flu (Influenza) Vaccine Price ($) by Types (2015-2020)
Table Global Flu (Influenza) Vaccine Market Forecast Sales by Types (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Sales Share by Types (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Revenue ($) by Types (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Revenue Share by Types (2020-2025)
Figure Global Inactivated Influenza Vaccines (IIV) Sales and Growth Rate (2015-2020)
Figure Global Inactivated Influenza Vaccines (IIV) Price (2015-2020)
Figure Global Live Attenuated Influenza Vaccines (LAIV) Sales and Growth Rate (2015-2020)
Figure Global Live Attenuated Influenza Vaccines (LAIV) Price (2015-2020)
Figure Global Flu (Influenza) Vaccine Market Revenue ($) and Growth Rate Forecast of Inactivated Influenza Vaccines (IIV) (2020-2025)
Figure Global Flu (Influenza) Vaccine Sales and Growth Rate Forecast of Inactivated Influenza Vaccines (IIV) (2020-2025)
Figure Global Flu (Influenza) Vaccine Market Revenue ($) and Growth Rate Forecast of Live Attenuated Influenza Vaccines (LAIV) (2020-2025)
Figure Global Flu (Influenza) Vaccine Sales and Growth Rate Forecast of Live Attenuated Influenza Vaccines (LAIV) (2020-2025)
Table Global Flu (Influenza) Vaccine Sales by Applications (2015-2020)
Table Global Flu (Influenza) Vaccine Sales Share by Applications (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue ($) by Applications (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue Share by Applications (2015-2020)
Table Global Flu (Influenza) Vaccine Market Forecast Sales by Applications (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Sales Share by Applications (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Revenue Share by Applications (2020-2025)
Figure Global For Children (6 months to 3 years) Sales and Growth Rate (2015-2020)
Figure Global For Children (6 months to 3 years) Price (2015-2020)
Figure Global For Adults and Children over 3 years Sales and Growth Rate (2015-2020)
Figure Global For Adults and Children over 3 years Price (2015-2020)
Figure Global Flu (Influenza) Vaccine Market Revenue ($) and Growth Rate Forecast of For Children (6 months to 3 years) (2020-2025)
Figure Global Flu (Influenza) Vaccine Sales and Growth Rate Forecast of For Children (6 months to 3 years) (2020-2025)
Figure Global Flu (Influenza) Vaccine Market Revenue ($) and Growth Rate Forecast of For Adults and Children over 3 years (2020-2025)
Figure Global Flu (Influenza) Vaccine Sales and Growth Rate Forecast of For Adults and Children over 3 years (2020-2025)
Figure Global Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Table Global Flu (Influenza) Vaccine Sales by Regions (2015-2020)
Table Global Flu (Influenza) Vaccine Sales Market Share by Regions (2015-2020)
Figure Global Flu (Influenza) Vaccine Sales Market Share by Regions in 2019
Figure Global Flu (Influenza) Vaccine Revenue and Growth Rate (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue by Regions (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue Market Share by Regions (2015-2020)
Figure Global Flu (Influenza) Vaccine Revenue Market Share by Regions in 2019
Table Global Flu (Influenza) Vaccine Market Forecast Sales by Regions (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Sales Share by Regions (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure North America Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
Figure North America Flu (Influenza) Vaccine Market Forecast Sales (2020-2025)
Figure North America Flu (Influenza) Vaccine Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Canada Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Mexico Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Europe Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Europe Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
Figure Europe Flu (Influenza) Vaccine Market Forecast Sales (2020-2025)
Figure Europe Flu (Influenza) Vaccine Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure France Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Italy Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Spain Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Russia Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Flu (Influenza) Vaccine Market Forecast Sales (2020-2025)
Figure Asia-Pacific Flu (Influenza) Vaccine Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Japan Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure South Korea Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Australia Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure India Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure South America Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure South America Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
Figure South America Flu (Influenza) Vaccine Market Forecast Sales (2020-2025)
Figure South America Flu (Influenza) Vaccine Market Forecast Revenue ($) (2020-2025)
Figure Brazil Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Argentina Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Columbia Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Flu (Influenza) Vaccine Market Forecast Sales (2020-2025)
Figure Middle East and Africa Flu (Influenza) Vaccine Market Forecast Revenue ($) (2020-2025)
Figure UAE Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Egypt Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure South Africa Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Product Picture
Figure Global Flu (Influenza) Vaccine Market Size and Growth Rate 2015-2025
Table Flu (Influenza) Vaccine Key Market Segments
Figure Global Flu (Influenza) Vaccine Market Revenue ($) Segment by Type from 2015-2020
Figure Global Flu (Influenza) Vaccine Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Flu (Influenza) Vaccine
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Pfizer Company Profile
Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Production and Growth Rate
Figure Pfizer Market Revenue ($) Market Share 2015-2020
Table Novavax Company Profile
Table Novavax Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novavax Production and Growth Rate
Figure Novavax Market Revenue ($) Market Share 2015-2020
Table Emergent BioSolutions Company Profile
Table Emergent BioSolutions Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Emergent BioSolutions Production and Growth Rate
Figure Emergent BioSolutions Market Revenue ($) Market Share 2015-2020
Table Sanofi Pasteur Company Profile
Table Sanofi Pasteur Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sanofi Pasteur Production and Growth Rate
Figure Sanofi Pasteur Market Revenue ($) Market Share 2015-2020
Table CSL (Novartis) Company Profile
Table CSL (Novartis) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure CSL (Novartis) Production and Growth Rate
Figure CSL (Novartis) Market Revenue ($) Market Share 2015-2020
Table Inovio Pharmaceuticals Company Profile
Table Inovio Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Inovio Pharmaceuticals Production and Growth Rate
Figure Inovio Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Bavarian Nordic Company Profile
Table Bavarian Nordic Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bavarian Nordic Production and Growth Rate
Figure Bavarian Nordic Market Revenue ($) Market Share 2015-2020
Table GlaxoSmithKline Company Profile
Table GlaxoSmithKline Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Market Revenue ($) Market Share 2015-2020
Table Merck & Co Company Profile
Table Merck & Co Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Merck & Co Production and Growth Rate
Figure Merck & Co Market Revenue ($) Market Share 2015-2020
Table Mitsubishi Tanabe Pharma Company Profile
Table Mitsubishi Tanabe Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Mitsubishi Tanabe Pharma Production and Growth Rate
Figure Mitsubishi Tanabe Pharma Market Revenue ($) Market Share 2015-2020
Table Global Flu (Influenza) Vaccine Sales by Types (2015-2020)
Table Global Flu (Influenza) Vaccine Sales Share by Types (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue ($) by Types (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue Share by Types (2015-2020)
Table Global Flu (Influenza) Vaccine Price ($) by Types (2015-2020)
Table Global Flu (Influenza) Vaccine Market Forecast Sales by Types (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Sales Share by Types (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Revenue ($) by Types (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Revenue Share by Types (2020-2025)
Figure Global Inactivated Influenza Vaccines (IIV) Sales and Growth Rate (2015-2020)
Figure Global Inactivated Influenza Vaccines (IIV) Price (2015-2020)
Figure Global Live Attenuated Influenza Vaccines (LAIV) Sales and Growth Rate (2015-2020)
Figure Global Live Attenuated Influenza Vaccines (LAIV) Price (2015-2020)
Figure Global Flu (Influenza) Vaccine Market Revenue ($) and Growth Rate Forecast of Inactivated Influenza Vaccines (IIV) (2020-2025)
Figure Global Flu (Influenza) Vaccine Sales and Growth Rate Forecast of Inactivated Influenza Vaccines (IIV) (2020-2025)
Figure Global Flu (Influenza) Vaccine Market Revenue ($) and Growth Rate Forecast of Live Attenuated Influenza Vaccines (LAIV) (2020-2025)
Figure Global Flu (Influenza) Vaccine Sales and Growth Rate Forecast of Live Attenuated Influenza Vaccines (LAIV) (2020-2025)
Table Global Flu (Influenza) Vaccine Sales by Applications (2015-2020)
Table Global Flu (Influenza) Vaccine Sales Share by Applications (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue ($) by Applications (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue Share by Applications (2015-2020)
Table Global Flu (Influenza) Vaccine Market Forecast Sales by Applications (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Sales Share by Applications (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Revenue Share by Applications (2020-2025)
Figure Global For Children (6 months to 3 years) Sales and Growth Rate (2015-2020)
Figure Global For Children (6 months to 3 years) Price (2015-2020)
Figure Global For Adults and Children over 3 years Sales and Growth Rate (2015-2020)
Figure Global For Adults and Children over 3 years Price (2015-2020)
Figure Global Flu (Influenza) Vaccine Market Revenue ($) and Growth Rate Forecast of For Children (6 months to 3 years) (2020-2025)
Figure Global Flu (Influenza) Vaccine Sales and Growth Rate Forecast of For Children (6 months to 3 years) (2020-2025)
Figure Global Flu (Influenza) Vaccine Market Revenue ($) and Growth Rate Forecast of For Adults and Children over 3 years (2020-2025)
Figure Global Flu (Influenza) Vaccine Sales and Growth Rate Forecast of For Adults and Children over 3 years (2020-2025)
Figure Global Flu (Influenza) Vaccine Sales and Growth Rate (2015-2020)
Table Global Flu (Influenza) Vaccine Sales by Regions (2015-2020)
Table Global Flu (Influenza) Vaccine Sales Market Share by Regions (2015-2020)
Figure Global Flu (Influenza) Vaccine Sales Market Share by Regions in 2019
Figure Global Flu (Influenza) Vaccine Revenue and Growth Rate (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue by Regions (2015-2020)
Table Global Flu (Influenza) Vaccine Revenue Market Share by Regions (2015-2020)
Figure Global Flu (Influenza) Vaccine Revenue Market Share by Regions in 2019
Table Global Flu (Influenza) Vaccine Market Forecast Sales by Regions (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Sales Share by Regions (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Flu (Influenza) Vaccine Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure North America Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
Figure North America Flu (Influenza) Vaccine Market Forecast Sales (2020-2025)
Figure North America Flu (Influenza) Vaccine Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Canada Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Mexico Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Europe Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Europe Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
Figure Europe Flu (Influenza) Vaccine Market Forecast Sales (2020-2025)
Figure Europe Flu (Influenza) Vaccine Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure France Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Italy Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Spain Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Russia Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Flu (Influenza) Vaccine Market Forecast Sales (2020-2025)
Figure Asia-Pacific Flu (Influenza) Vaccine Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Japan Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure South Korea Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Australia Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure India Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure South America Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure South America Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
Figure South America Flu (Influenza) Vaccine Market Forecast Sales (2020-2025)
Figure South America Flu (Influenza) Vaccine Market Forecast Revenue ($) (2020-2025)
Figure Brazil Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Argentina Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Columbia Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Flu (Influenza) Vaccine Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Flu (Influenza) Vaccine Market Forecast Sales (2020-2025)
Figure Middle East and Africa Flu (Influenza) Vaccine Market Forecast Revenue ($) (2020-2025)
Figure UAE Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure Egypt Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
Figure South Africa Flu (Influenza) Vaccine Market Sales and Growth Rate (2015-2020)
